Difference between revisions of "Minutes - Medication WG 2022-05-24"
From Health Level 7 Belgium Wiki
KarlienErauw (talk | contribs) (Created page with "===== '''Attendees''' ===== * Bart Decuypere * Jens Penny * José Costa Teixeira * Karlien Erauw * Nick Hermans * Pablo Christiaens * Tom Henkens ===== '''Excused/Not pre...") |
KarlienErauw (talk | contribs) |
||
| Line 35: | Line 35: | ||
* Work on business rules is ongoing based upon the use case, have to be part of the implementation guide | * Work on business rules is ongoing based upon the use case, have to be part of the implementation guide | ||
* We need some documentation for the migration from Kmehr to FHIR: input is needed | * We need some documentation for the migration from Kmehr to FHIR: input is needed | ||
| − | + | * We have to complexities of contraindications and (drug) allergies & intolerances | |
| − | + | ::* drug allergies & intolerances are related to decision support, therefore might not be needed to include in the medication scheme but offer as additional service | |
| + | ::* modelling of contraindications needs still to be determined, which can also be temporarily (f.e. pregnancy) | ||
| + | ::* allergy & intolerance will be the way to present this kind of info | ||
::* access matrix is being worked on by RIZIV | ::* access matrix is being worked on by RIZIV | ||
Revision as of 09:24, 24 May 2022
Attendees
- Bart Decuypere
- Jens Penny
- José Costa Teixeira
- Karlien Erauw
- Nick Hermans
- Pablo Christiaens
- Tom Henkens
Excused/Not present
- Anne Nerenhausen
- Annemieke Vergauwe
- Bruno Casneuf
- Dieter Sauvillers
- Elhassan Baazizi
- Hanne Vuegen
- Jan Lenie
- Jean-Louis Maggetto
- Jean-Michel Polfliet
- Katrien Thorré
- Lars Vanreppelen
- Marc Buckens
- Nick Hermans
- Nils Devos
- Richard Francken
- Thomas Van Langendonck
- Tom De Backer
- Walter Bollaert
- Will van Norel
Agenda
- Future of medication scheme
Minutes
- Work on business rules is ongoing based upon the use case, have to be part of the implementation guide
- We need some documentation for the migration from Kmehr to FHIR: input is needed
- We have to complexities of contraindications and (drug) allergies & intolerances
- drug allergies & intolerances are related to decision support, therefore might not be needed to include in the medication scheme but offer as additional service
- modelling of contraindications needs still to be determined, which can also be temporarily (f.e. pregnancy)
- allergy & intolerance will be the way to present this kind of info
- access matrix is being worked on by RIZIV
- Presentation of medication treatment and view line examples is not possible due to broken build
- Meeting adjourned at 11.10AM due to limited audience
Action items for next meeting
- José to complete addition of medication view and treatment lines and how it all works at operational level
Agenda items for next meeting
- Presentation of medication treatment and view line examples
Next meeting June 7 at 11AM
